Related Experiment Videos

Reversible neutropenia associated with ampicillin therapy in pediatric patients

Insights

High-dose ampicillin can cause neutropenia (low neutrophil count) in children. This condition is rare but reversible after discontinuing the antibiotic treatment.

Area of Science:

  • Pediatric Hematology
  • Pharmacology
  • Clinical Toxicology

Background:

  • Penicillin compounds are rarely associated with hematologic abnormalities.
  • Neutropenia, a decrease in neutrophils, is an infrequent side effect of ampicillin therapy.

Observation:

  • Three pediatric patients developed neutropenia following high-dose ampicillin treatment (150-400 mg/kg/day) over 3–12 days.
  • Bone marrow examinations indicated maturation arrest or a left shift in granulocytic cell maturation.
  • Other hematologic parameters, including red blood cells and platelets, remained unaffected.

Findings:

  • Neutropenia resolved in all patients within 4–11 days after ampicillin cessation.
  • The observed neutropenia was reversible, with neutrophil counts normalizing post-treatment.

Implications:

  • Clinicians should monitor for neutropenia in pediatric patients receiving high-dose ampicillin.
  • Awareness of this potential adverse effect is crucial for safe antibiotic administration.
  • Prompt recognition and discontinuation of ampicillin can lead to full recovery.

Related Concept Videos